Wolverine Trading
AXSM icon

Wolverine Trading’s Axsome Therapeutics AXSM Stock Holding History

Wolverine Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.05M Buy
25,900
+10,700
+70% +$1.21M ﹤0.01% 1802
2025
Q2 		$1.57M Sell
15,200
-16,500
-52% -$1.75M ﹤0.01% 1886
2025
Q1 		$3.76M Sell
31,700
-20,000
-39% -$2.28M ﹤0.01% 1162
2024
Q4 		$4.38M Buy
51,700
+18,700
+57% +$1.72M ﹤0.01% 1299
2024
Q3 		$2.96M Buy
33,000
+12,700
+63% +$1.11M ﹤0.01% 1413
2024
Q2 		$1.63M Buy
20,300
+4,500
+28% +$333K ﹤0.01% 1747
2024
Q1 		$1.26M Sell
15,800
-9,600
-38% -$806K ﹤0.01% 1993
2023
Q4 		$2.02M Buy
25,400
+9,300
+58% +$622K ﹤0.01% 1718
2023
Q3 		$1.13M Sell
16,100
-9,900
-38% -$740K ﹤0.01% 2035
2023
Q2 		$1.9M Sell
26,000
-4,200
-14% -$310K ﹤0.01% 1502
2023
Q1 		$1.83M Sell
30,200
-1,800
-6% -$118K ﹤0.01% 1425
2022
Q4 		$2.47M Buy
32,000
+6,800
+27% +$406K ﹤0.01% 1261
2022
Q3 		$1.11M Buy
+25,200
New +$1.26M ﹤0.01% 1861

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wolverine Trading's AXSM Position: Q3 2025 in Review

Wolverine Trading increased its Axsome Therapeutics (AXSM) stake by 3.1% in Q3 2025, buying an estimated $61.7K and bringing the position to 18,157 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Wolverine Trading first reported a position in AXSM in Q3 2022 and has held it in 11 quarters since. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Wolverine Trading held 18,157 shares of Axsome Therapeutics worth $2.14M as of Q3 2025.
  • Wolverine Trading bought 548 Axsome Therapeutics shares in Q3 2025, an estimated $61.7K.
  • Axsome Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2121 holding.
  • Wolverine Trading first reported a position in Axsome Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.